Mans Broekgaarden holds a BSc degree in Biomedical Sciences from the Utrecht University of Applied Sciences, and a MSc degree in Biomolecular Sciences from the VU University Amsterdam. He obtained his PhD degree in 2016, after completing his doctorate research in the group of Dr. Michal Heger at the University of Amsterdam. Subsequently, he did a postdoctoral fellowship in the group of Prof. Tayyaba Hasan at the Wellman Center for Photomedicine, a thematical research center of Massachusetts General Hospital and Harvard Medical School. He currently continues his career at the Institute for Advanced Biosciences, Grenoble-Alpes University, where he leads a project on controlled drug delivery with photodynamic- and radiotherapeutics. I have extensive expertise in the development of liposomal photonanomedicines, experimental cancer therapies, and patient derived organoid and xenograft models of cancer. I obtained my PhD from the \textbf{Academic Medical Center, University of Amsterdam} and completed my postdoctoral training at \textbf{Harvard Medical School, Massachusetts General Hospital}. I am currently at the \textbf{Institute for Advanced Biosciences, CNRS UMR 5309 (Grenoble, France)}. In July 2019 I became an elected member of the \textbf{Board of Directors} of the \textbf{International Photodynamic Association}, the world's leading association for Photodynamic Therapy and Photodynamic Diagnosis.